BioNTech and Fosun Pharma Initiate P-ll Study of BNT162b2 Against COVID-19 in China
Shots: The companies initiated the P-II study of their COVID-19 vaccine in China. The trial will generate data to support the BLA filing for approval […]
Shots: The companies initiated the P-II study of their COVID-19 vaccine in China. The trial will generate data to support the BLA filing for approval […]
Shots: J&J has resumed recruitment, enrolment, and vaccination in all studies of its COVID-19 vaccine across the EU, after a temporary pause. Trials in the […]
Shots: The US FDA authorizes the restart of the P-III clinical study in the US following the resumption of trials in other countries in recent […]
Shots: The P-I/II study of AZD1222 has resumed in Japan following the discussion with the PMDA. Additionally, the company is in talks with the US […]
Shots: The company resumes the P-III program (explorer6, 7, and 8) of concizumab. The clinical trials are evaluating concizumab (SC) prophylaxis treatment in hemophilia A […]
Copyright © 2024 | WordPress Theme by MH Themes